Skip to main content

Table 1 Clinical information for lung adenocarcinoma samples profiled

From: Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology

Characteristic

NS1

CS2

FS3

Number

27

43

24

Sex

   

Male

7 (26%)

13 (30%)

9 (38%)

Female

20 (74%)

30 (70%)

15 (62%)

Average age

71

64

71

Stage

   

I

16 (59%)

26 (60%)

16 (67%)

II

6 (22%)

11 (26%)

6 (25%)

III

5 (19%)

4 (9%)

1 (4%)

IV

0

2 (5%)

1 (4%)

Ethnicity

   

Caucasian

8 (30%)

11 (26%)

1 (4%)

Asian

16 (59%)

0 (0%)

0 (0%)

Unknown

3 (11%)

32 (74%)

23 (96%)

Average pack years

0

46

47

Average years quit

n/a

< 1

15

  1. 1NS as patients who smoked fewer than 100 cigarettes in their lifetime. 2CS were defined as smoking at the time of diagnosis. 3FS as individuals who had stopped smoking at least one year prior to diagnosis.